Buying Precigen Inc. (PGEN) Stock Is A Smart Move Today?

0
20

Precigen Inc. (NASDAQ:PGEN) finished Wednesday with a subtraction of -$0.54 to close at $1.65, a downside of -24.66 percent. An average of 4,059,060 shares of common stock have been traded in the last five days. There was a fall of -$0.46 in the past week, and it reached a new high 1 time over the past 12 months. The last 20 days have seen an average of 1,639,055 shares traded, while the 50-day average volume stands at 1,124,944.

PGEN stock has increased by 16.20% in the last month. The company shares reached their 1-month lowest point of $1.26 on 12/27/22. With the stock rallying to its 52-week high on 01/23/23, shares of the company touched a low of $1.12 and a high of $3.00 in 52 weeks. It has reached a new high 10 times so far this year and achieved 8.55% or $0.13 in price. In spite of this, the price is down -45.00% from the 52-week high.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…

Sponsored

Insider Transactions

PGEN stock investors should be aware that Precigen Inc. (PGEN) stock had its last reported insider trading activity 168 days ago on Aug 23. In this transaction, the insider spent $115,000. SVP, IP Affairs, Perez Jeffrey Thomas, disposed of 14,778 shares at a price of $1.28 on May 17. The insider now owns more than $18,916 worth of shares. Prior to that, Chief Financial Officer Thomasian Harry Jr. went on to Sale 2,719 shares at $1.28 each on May 17. An amount of $3,480 was transacted.

Valuation Metrics

Precigen Inc. (PGEN) stock’s beta is 1.90. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 6.74, the price-to-book (PB) ratio at 2.32.

Financial Health

The quick ratio of Precigen Inc. for the three months ended September 29 was 1.60, and the current ratio was 1.60, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.00 and a total debt to equity ratio of 0.58 for the quarter ending September 29. Its gross profit as reported stood at $45.49 million compared to revenue of $103.87 million.

For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Precigen Inc.’s return on assets was 8.00%.

Earnings Surprise

For the three-month period that ended September 29, Precigen Inc. had $62.26 million in cash. In the quarter under review, the net income was up than the previous quarter. The company posted a net income of $87.38 million in the quarter, while revenues of -$17.64 million were grew 134.06%. The analyst consensus anticipated Precigen Inc.’s latest quarter earnings to come in at $0.02 per share, but it turned out to be $0.44, a 2,100.00% surprise. For the quarter, EBITDA amounted to -$4.55 million. Shareholders own equity worth $208.15 million.

Technical Picture

From a technical analysis perspective, let’s take a brief look at Precigen Inc. (PGEN) price momentum. RSI 9-day as of the close on 25 January was 41.54%, suggesting the stock is Neutral, with historical volatility in this time frame at 185.36%.

As of today, PGEN’s price is $1.99 -21.80% or -$0.46 from its 5-day moving average. PGEN is currently trading +17.86% higher than its 20-day SMA and -25.34% lower than its 100-day SMA. However, the stock’s current price level is -7.30% below the SMA50 and -27.95% below the SMA200.

The stochastic %K and %D were 64.39% and 75.13%, respectively, and the average true range (ATR) was 0.23. With the 14-day stochastic at 19.55% and the average true range at 0.19, the RSI (14) stands at 45.71%. The stock has reached 0.01 on the 9-day MACD Oscillator while the 14-day reading was at 0.16.

Analyst Ratings

Cantor Fitzgerald launched coverage on Precigen Inc. (NASDAQ: PGEN) in its analyst report released on November 18, 2022. The firm assigned the stock an Overweight rating. The consensus rating for Precigen Inc. (PGEN) among analysts is Buy. According to current brokerage recommendations, 0 brokerage firms advise that investors sell PGEN, while 0 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 4 others rate it as a “buy”.

What is PGEN’s price target for the next 12 months?

Analysts predict a range of price targets between $6.00 and $14.00, with a median target of $6.55. Taking a look at these predictions, the average price target given by analysts for Precigen Inc. (PGEN) stock is $8.28.

LEAVE A REPLY

Please enter your comment!
Please enter your name here